Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy

Clinical trial NCT02811627 · COMPLETED

Trial details

NCT number: NCT02811627
Sponsor: University of Missouri-Columbia
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2016-06-01
Primary completion: 2021-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.